Evidence map›Paper›PMID 37816155›Full record

ArticleAnalytical chemistry2023

Cleavable Cross-Linkers Redefined by a Novel MS

Lars Kolbowski, Lutz Fischer, Juri Rappsilber

Abstract read
In one paragraph

Article in Analytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lars KolbowskiTechnische Universität Berlin, Chair of Bioanalytics, 10623 Berlin, Germany.ORCID 0000-0001-6819-6570
Lutz FischerTechnische Universität Berlin, Chair of Bioanalytics, 10623 Berlin, Germany.ORCID 0000-0003-4978-0864
Juri RappsilberTechnische Universität Berlin, Chair of Bioanalytics, 10623 Berlin, Germany.ORCID 0000-0001-5999-1310

Funding

Wellcome Trust
6 · The paper itself

Abstract

Cross-linking mass spectrometry (MS) is currently transitioning from a routine tool in structural biology to enabling structural systems biology. MS-cleavable cross-linkers could substantially reduce the associated search space expansion by allowing a MS

Indexed as

PeptidesTandem Mass SpectrometryAlgorithmsCross-Linking ReagentsMolecular BiologyCross-Linking ReagentsPeptides

Identifiers

PMID37816155
PMCPMC10603603

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.